Candesartan cilexetil 16 MG TB 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FW043
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,451
Award facts
- Contract value 100% obligated
- $17,451.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On February 4, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $17,451.27 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles). This firm fixed-price, competitively awarded contract with no set-aside designation is scheduled for completion by February 5, 2026, and will be performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical federal vendor specializing in supplying medications, vaccines, medical devices, and healthcare commodities to military and veteran healthcare systems. The company's extensive portfolio of federal awards demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains, ranging from specialty medications to generic drugs and medical supplies. This contract supports the Defense Health Agency and other government healthcare systems in maintaining essential medication inventories for military treatment facilities and related federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FW043?
SPE2DR26FW043 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FW043 worth?
The government has obligated $17,451 on SPE2DR26FW043.
Is contract SPE2DR26FW043 an order under another contract?
Yes. SPE2DR26FW043 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FW043 competed?
The extent of competition for SPE2DR26FW043 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award